| Citation: |
ZHANG Junrou, ZHANG Shixuan, LI Jie, NIU Piye. Bioinformatics study on role of IL-17 signaling in manganese poisoning and manganese-related neurodegenerative diseases[J]. Journal of Environmental and Occupational Medicine, 2022, 39(10): 1140-1145. DOI: 10.11836/JEOM22157
|
Manganese (Mn) is one of the environmental factors of Parkinson's disease (PD), and long-term exposure to Mn can cause nerve damage. It is important to explore the common mechanism of neurotoxic effects of Mn and neurodegenerative diseases (NDD), especially PD, for early diagnosis of the disease.
To comprehensively analyze the core messenger RNA (mRNA)-microRNAs (miRNAs) co-expressed in frontal cortex of NDD patients and neuronal cells exposed to Mn via bioinformatics, and to reveal the potential common mechanism between Mn-induced neurotoxicity and NDD, especially PD.
Difference of the mRNAs from frontal cortex of NDD patients (GSE150696) and human neuroblastoma (SH-SY5Y) cells exposed to Mn were analyzed by R software; Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed on the overlapping differentially expressed genes (DEGs). The miRNAs were predicted using the miRNet database, mRNA-miRNA interactions were identified by the starBase and miRTarBase databases, and mRNA-miRNA regulatory networks were constructed with Cytoscape software. The core miRNAs associated with PD (GSE77667) were incorporated into Weighted Gene Co-Expression Network Analysis (WGCNA) and the mRNA-miRNA regulatory network was comparatively analyzed.
A total of 34 overlapping DEGs were identified in the frontal cortical of NDD patients and the neuronal cells exposed to Mn, mainly enriched in interleukin-17 (IL-17) signaling pathway, cyclic adenosine monophosphate (cAMP) signaling pathway, and primary immunodeficiency. Based on the results of database prediction, 52 miRNAs with 71 pairs of interaction relationships were finally included to construct the miRNA-mRNA regulatory network. Six core miRNAs were screened by WGCNA: hsa-let-7i-5p, hsa-mir-155-5p, hsa-mir-219-2-3p, hsa-mir-221-3p, hsa-mir-485-3p, and hsa-mir-509-3-5p, among which hsa-let-7i-5p interacted with the target gene FBXW2 and hsa-mir-155-5p interacted with the target gene CCL2. The results of the KEGG analysis indicated that CCL2 was closely related to the IL-17 signaling pathway.
There are similar molecular regulatory mechanisms involved in the neurotoxicity of Mn and NDD, and the IL-17 signaling pathway may play a role in Mn-related NDD through CCL2 and hsa-mir-155-5p.
| [1] |
MARTINS A C Jr, GUBERT P, VILLAS BOAS G R, et al. Manganese-induced neurodegenerative diseases and possible therapeutic approaches[J]. Expert Rev Neurother, 2020, 20(11): 1109-1121. doi: 10.1080/14737175.2020.1807330
|
| [2] |
GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2018, 17(11): 939-953. doi: 10.1016/S1474-4422(18)30295-3
|
| [3] |
YANG T, ZHAN Z, ZHANG L, et al. Prevalence and risk factors for malnutrition in patients with Parkinson's disease[J]. Front Neurol, 11: 533731.
|
| [4] |
DORSEY E R, SHERER T, OKUN M S, et al. The emerging evidence of the Parkinson pandemic[J]. J Parkinsons Dis, 2018, 8(S1): S3-S8. doi: 10.3233/JPD-181474
|
| [5] |
LUCCHINI R G, ASCHNER M, LANDRIGAN P J, et al. Neurotoxicity of manganese: indications for future research and public health intervention from the Manganese 2016 conference[J]. NeuroToxicology, 2018, 64: 1-4. doi: 10.1016/j.neuro.2018.01.002
|
| [6] |
BALACHANDRAN R C, MUKHOPADHYAY S, MCBRIDE D, et al. Brain manganese and the balance between essential roles and neurotoxicity[J]. J Biol Chem, 2020, 295(19): 6312-6329. doi: 10.1074/jbc.REV119.009453
|
| [7] |
PAJARILLO E, JOHNSON J Jr, RIZOR A, et al. Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity[J]. J Biol Chem, 2020, 295(46): 15662-15676. doi: 10.1074/jbc.RA120.015552
|
| [8] |
NYARKO-DANQUAH I, PAJARILLO E, DIGMAN A, et al. Manganese accumulation in the brain via various transporters and its neurotoxicity mechanisms[J]. Molecules, 2020, 25(24): 5880. doi: 10.3390/molecules25245880
|
| [9] |
SRIRAM K, LIN G X, JEFFERSON A M, et al. Modifying welding process parameters can reduce the neurotoxic potential of manganese-containing welding fumes[J]. Toxicology, 2015, 328: 168-178. doi: 10.1016/j.tox.2014.12.015
|
| [10] |
MIAH M R, IJOMONE O M, OKOH C O A, et al. The effects of manganese overexposure on brain health[J]. Neurochem Int, 2020, 135: 104688. doi: 10.1016/j.neuint.2020.104688
|
| [11] |
CHEN X, CAO W, ZHUANG Y, et al. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson’s disease[J]. Brain Res Bull, 2021, 177: 53-63. doi: 10.1016/j.brainresbull.2021.09.010
|
| [12] |
KHAN I, PREETI K, FERNANDES V, et al. Role of MicroRNAs, aptamers in neuroinflammation and neurodegenerative disorders[J]. Cell Mol Neurobiol, 2022, 42(7): 2075-2095. doi: 10.1007/s10571-021-01093-4
|
| [13] |
SUN X, XUE H, XIONG Y, et al. GALE promotes the proliferation and migration of glioblastoma cells and is regulated by miR-let-7i-5p[J]. Cancer Manag Res, 2019, 11: 10539-10554. doi: 10.2147/CMAR.S221585
|
| [14] |
JIN J, QIAN F, ZHENG D, et al. Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA Let-7i-5p antagomir[J]. Int J Nanomedicine, 2021, 16: 3565-3578. doi: 10.2147/IJN.S299969
|
| [15] |
XU J, ZHOU W, YANG F, et al. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor[J]. Nat Commun, 2017, 8: 14002. doi: 10.1038/ncomms14002
|
| [16] |
YANG F, XU J, LI H, et al. FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation[J]. Nat Commun, 2019, 10(1): 1382. doi: 10.1038/s41467-019-09289-5
|
| [17] |
CAGGIU E, PAULUS K, MAMELI G, et al. Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients[J]. eNeurologicalSci, 2018, 13: 1-4. doi: 10.1016/j.ensci.2018.09.002
|
| [18] |
LV R, DU L, ZHOU F, et al. Rosmarinic acid alleviates inflammation, apoptosis, and oxidative stress through regulating miR-155-5p in a mice model of Parkinson’s disease[J]. ACS Chem Neurosci, 2020, 11(20): 3259-3266. doi: 10.1021/acschemneuro.0c00375
|
| [19] |
SAWYER A J, TIAN W, SAUCIER-SAWYER J K, et al. The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation[J]. Biomaterials, 2014, 35(25): 6698-6706. doi: 10.1016/j.biomaterials.2014.05.008
|
| [20] |
POPICHAK K A, AFZALI M F, KIRKLEY K S, et al. Glial-neuronal signaling mechanisms underlying the neuroinflammatory effects of manganese[J]. J Neuroinflammation, 2018, 15(1): 324. doi: 10.1186/s12974-018-1349-4
|
| [21] |
KEMPURAJ D, THANGAVEL R, FATTAL R, et al. Mast cells release chemokine CCL2 in response to Parkinsonian toxin 1-methyl-4-phenyl-pyridinium (MPP+)[J]. Neurochem Res, 2016, 41(5): 1042-1049. doi: 10.1007/s11064-015-1790-z
|
| [22] |
RÉAUX-LE GOAZIGO A, VAN STEENWINCKEL J, ROSTÈNE W, et al. Current status of chemokines in the adult CNS[J]. Prog Neurobiol, 2013, 104: 67-92. doi: 10.1016/j.pneurobio.2013.02.001
|
| [23] |
BEUREL E, LOWELL J A. Th17 cells in depression[J]. Brain Behav Immun, 2018, 69: 28-34. doi: 10.1016/j.bbi.2017.08.001
|
| [24] |
DE VIRGILIO A, GRECO A, FABBRINI G, et al. Parkinson's disease: autoimmunity and neuroinflammation[J]. Autoimmun Rev, 2016, 15(10): 1005-1011. doi: 10.1016/j.autrev.2016.07.022
|
| [25] |
WOJKOWSKA D W, SZPAKOWSKI P, GLABINSKI A. Interleukin 17A promotes lymphocytes adhesion and induces CCL2 and CXCL1 release from brain endothelial cells[J]. Int J Mol Sci, 2017, 18(5): 1000. doi: 10.3390/ijms18051000
|
| [26] |
WAISMAN A, HAUPTMANN J, REGEN T. The role of IL-17 in CNS diseases[J]. Acta Neuropathol, 2015, 129(5): 625-637. doi: 10.1007/s00401-015-1402-7
|
| [27] |
LIU Z, QIU A W, HUANG Y, et al. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease[J]. Brain Behav Immun, 2019, 81: 630-645. doi: 10.1016/j.bbi.2019.07.026
|
| [28] |
SOMMER A, MARXREITER F, KRACH F, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson’s disease[J]. Cell Stem Cell, 2018, 23(1): 123-131.e6. doi: 10.1016/j.stem.2018.06.015
|
| [29] |
CRISTIANO C, VOLPICELLI F, LIPPIELLO P, et al. Neutralization of IL‐17 rescues amyloid‐β‐induced neuroinflammation and memory impairment[J]. Br J Pharmacol, 2019, 176(18): 3544-3557. doi: 10.1111/bph.14586
|
| [30] |
HU R, HUFFAKER T B, KAGELE D A, et al. MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression[J]. J Immunol, 2013, 190(12): 5972-5980. doi: 10.4049/jimmunol.1300351
|
| [31] |
AL-GHEZI Z Z, MIRANDA K, NAGARKATTI M, et al. Combination of cannabinoids, Δ9- tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of miRNA-mediated signaling pathways[J]. Front Immunol, 2019, 10: 1921. doi: 10.3389/fimmu.2019.01921
|
| [32] |
KSIAZEK-WINIAREK D, SZPAKOWSKI P, TURNIAK M, et al. IL-17 exerts anti-apoptotic effect via miR-155-5p downregulation in experimental autoimmune encephalomyelitis[J]. J Mol Neurosci, 2017, 63(3/4): 320-332.
|
| [33] |
O'CONNELL R M, KAHN D, GIBSON W S J, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development[J]. Immunity, 2010, 33(4): 607-619. doi: 10.1016/j.immuni.2010.09.009
|
| [34] |
EMAMZADEH F N, SURGUCHOV A. Parkinson’s disease: biomarkers, treatment, and risk factors[J]. Front Neurosci, 2018, 12: 612. doi: 10.3389/fnins.2018.00612
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: